Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women

Calcified Tissue International

Volumn 82, Issue 1, 2008, Pages 12-26

  Balla, Bernadett ^a   Kósa, János P ^a   Kiss, János ^a   Borsy, Adrienn ^b,c   Podani, János ^c   Takács, István ^a   Lazáry, Áron ^a   Nagy, Zsolt ^a   Bácsi, Krisztián ^a   Speer, Gábor ^a   Orosz, László ^b,c   Lakatos, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Canonical variates analysis; Human subjects; Osteoporosis; Principal components analysis; Transcriptional profiling

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; AGED; AGING; ALKALINE PHOSPHATASE GENE; ARTICLE; BONE TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MATRIX METALLOPROTEINASE 13 GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 9 GENE; MULTIVARIATE ANALYSIS; NUCLEAR FACTOR KAPPA B1 GENE; OSTEOPOROSIS; PHENOTYPE; PLATELET DERIVED GROWTH FACTOR A GENE; POSTMENOPAUSE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; THROMBOSPONDIN GENE; TWIST2 GENE; TYPE 1 COLLAGEN ALPHA 1 GENE;

AGED; AGING; BONE AND BONES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PRINCIPAL COMPONENT ANALYSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VARIATION (GENETICS);

EID: 39149088639     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-007-9092-3     Document Type: Article

References (53)

1. Prentice A (2001) The relative contribution of diet and genotype to bone development. Proc Nutr Soc 60:45-52
2. Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3-11
3. Ralston SH (2005) Genetic determinants of osteoporosis. Curr Opin Rheumatol 17:475-479
4. Zajickova K, Zofkova I (2003) Osteoporosis: Genetic analysis of multifactorial disease. Endocr Regul 37:31-44
5. Rizzoli R, Bonjour JP, Ferrari SL (2001) Osteoporosis, genetics and hormones. J Mol Endocrinol 26:79-94
6. Dvornyk V, Recker RR, Deng HW (2003) Gene expression studies of osteoporosis: Implications for microarray research. Osteoporos Int 14:451-461
7. Ralston SH (1994) Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9:883-890
8. Abrahamsen B, Shalhoub V, Larson EK, Eriksen EF, Beck-Nielsen H, Marks SC Jr (2000) Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women. Bone 26:137-145
9. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502
10. Jolliffe I (1986) Principal component analysis. Springer, Berlin Heidelberg New York
11. Podani J (2000) Introduction to the exploration of multivariate biological data. Backhuys, Leiden
12. Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: Application to sporulation time series. Pac Symp Biocomput [2000]:455-466
13. Yeung KY, Ruzzo WL (2001) Principal component analysis for clustering gene expression data. Bioinformatics 17:763-774
14. Dai JJ, Lieu L, Rocke D (2006) Dimension reduction for classification with gene expression microarray data. Stat Appl Genet Mol Biol 5:article 6
15. Cattell R (1966) The scree test for the number of factors. Multivar Behav Res 1:140-161
16. Podani J (2001) SYN-TAX 2000: User's manual. Scientia, Budapest
17. Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49-61
18. Gazzerro E, Canalis E (2006) Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51-65
19. Turner RT, Riggs BL, Spelsberg TC (1994) Skeletal effects of estrogen. Endocr Rev 15:275-300
20. Manolagas SC, Kousteni S, Jilka RL (2002) Sex steroids and bone. Recent Prog Horm Res 57:385-409
21. Christenson RH (1997) Biochemical markers of bone metabolism: An overview. Clin Biochem 30:573-593
22. Vega D, Maalouf NM, Sakhaee K (2007) The role of RANK/RANKL/OPG: Clinical implications. J Clin Endocrinol Metab 92(12):4514-4521
23. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233
24. 3. Artif Cells Blood Substit Immobil Biotechnol 30:219-227
25. Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82:583-590
26. Rodriguez JP, Montecinos L, Rios S, Reyes P, Martinez J (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79:557-565
27. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39:181-188
28. Cao J, Venton L, Sakata T, Halloran BP (2003) Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res 18:270-277
29. Carron JA, Wagstaff SC, Gallagher JA, Bowler WB (2000) A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro. Biochem Biophys Res Commun 270:1124-1127
30. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA (1998) Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39:777-788
31. Kawaguchi H, Akune T, Yamaguchi M, Ohba S, Ogata N, Chung UI, Kubota N, Terauchi Y, Kadowaki T, Nakamura K (2005) Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 23:275-279
32. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 3:379-389
33. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76-83
34. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229-240
35. Tamura M, Noda M (1999) Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells. J Cell Biochem 72:167-176
36. Gong XQ, Li L (2002) Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem 277:12310-12317
37. Lee MS, Lowe G, Flanagan S, Kuchler K, Glackin CA (2000) Human Dermo-1 has attributes similar to twist in early bone development. Bone 27:591-602
38. Schroeder TM, Westendorf JJ (2005) Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20:2254-2263
39. Leeman MF, Curran S, Murray GI (2002) The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37:149-166
40. Fridman R, Toth M, Pena D, Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555
41. Knauper V, Smith B, Lopez-Otin C, Murphy G (1997) Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem/FEBS 248:369-373
42. Hatori K, Sasano Y, Takahashi I, Kamakura S, Kagayama M, Sasaki K (2004) Osteoblasts and osteocytes express MMP2 and -8 and TIMP1, -2, and -3 along with extracellular matrix molecules during appositional bone formation. Anat Rec A 277:262-271
43. Filanti C, Dickson GR, Di Martino D, Ulivi V, Sanguineti C, Romano P, Palermo C, Manduca P (2000) The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res 15:2154-2168
44. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879-889
45. Rydziel S, Shaikh S, Canalis E (1994) Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures. Endocrinology 134:2541-2546
46. Hock JM, Canalis E (1994) Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 134:1423-1428
47. Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93:990-998
48. Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT (2002) Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J Endocrinol 174:63-70
49. Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17-25
50. Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y (2005) Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. J Immunol 175:7193-201
51. Ozeki N, Mogi M, Nakamura H, Togari A (2002) Differential expression of the Fas-Fas ligand system on cytokine-induced apoptotic cell death in mouse osteoblastic cells. Arch Oral Biol 47:511-517
52. Atkins GJ, Bouralexis S, Evdokiou A, Hay S, Labrinidis A, Zannettino AC, Haynes DR, Findlay DM (2002) Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone 31:448-56
53. Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL (2005) Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem Biophys Res Commun 333:42-50